<?xml version="1.0" encoding="UTF-8"?>
<paload id="" version="">
	<toplevel>
		<routedMedId>76704</routedMedId>
		<routedMedName>Crestor 20 mg tablet</routedMedName>
		<routedGenericName>rosuvastatin 20 mg tablet</routedGenericName>
		<etcIds>
			<etc_id/>
		</etcIds>
		<medIds>
			<medId>451300</medId>
		</medIds>
	</toplevel>
	<diagnoses>
		<diagnosis>
			<fqn>Hypercholesterolemia</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>22.701</icd9>
			<symbolic>crestcholes</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name></name>
			</genotype>
			<polymorphism>
				<name></name>
			</polymorphism>
			<subtype>
				<name></name>
			</subtype>
			<severity>
				<name></name>
				<code></code>
				<dur></dur>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name/>
					<code/>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype></subtype>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur></dur>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>any</numRequired>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>atorvastatin 80 mg tablet </name>
								<codeValues>158585</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
			</triedTherapyExclusion>
			<dosing>
				<text>20 mg orally once daily</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>451300</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>30 tablets for 30 days</initPerIntervalDesc>
					<renewPerDayDesc>1 tablet</renewPerDayDesc>
					<renewPerIntervalDesc>30 tablets for 30 days</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur/>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Crestor [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2014</reference>
				<reference>Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB,  Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PWF. 2013 ACC/AHA  guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S1â€“S45.</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
		<diagnosis>
			<fqn>Heterozygous Familial Hypercholesterolemia in Pediatric Patients</fqn>
			<age>
				<ageRangeType>range</ageRangeType>
				<ageRangeMin>10</ageRangeMin>
				<ageRangeMax>17</ageRangeMax>
				<ageRangeUnit>nocode</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>23.05</icd9>
			<symbolic>cresthfh</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype>
				<name/>
			</subtype>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name/>
					<code/>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>any</numRequired>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>03.163181|03.286606|03.209275|03.150475|03.245894|03.173289|03.268217|03.158596|03.294944|03.184650|03.217974|03.241540</codeValues>
								<selectedListName>HMG-CoA Reductase Inhibitors</selectedListName>
								<selectedListClassCode>16.09</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>all</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
			</triedTherapyExclusion>
			<dosing>
				<text>20 mg orally once daily</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>451300</medId>
					<initPerDayDesc>1 tablet per day</initPerDayDesc>
					<initPerIntervalDesc>30 tablets per 30 days</initPerIntervalDesc>
					<renewPerDayDesc>1 tablet per day</renewPerDayDesc>
					<renewPerIntervalDesc>30 tablets per 30 days</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur/>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Crestor [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2014</reference>
				<reference>Lipitor [package insert]. New York, NY: Parke-Davis Div of Pfizer Inc; 2014</reference>
				<reference>Zocor [package insert]. Whitehouse Station, NJ:  Merck &amp; Co, Inc; 2014</reference>
				<reference>Pravachol [package insert]. Princeton, NJ:  Bristol-Myers Squibb Company; 2013</reference>
				<reference>Mevacor [package insert]. Whitehouse Station, NJ:  Merck &amp; Co, Inc; 2014</reference>
				<reference>Lescol/Lescol XL [package insert]. East Hanover, NJ: Novartis; 2012</reference>
				<reference>Livalo [package insert]. Montgomery, AL: Kowa Pharmaceuticals America, Inc; 2013</reference>
				<reference>Altoprev [package insert]. Atlanta, GA: Shionogi Pharma, Inc; 2010</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
		<diagnosis>
			<fqn>Primary Prevention of Cardiovascular Disease</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>23.06</icd9>
			<symbolic>crestprevent</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype>
				<name/>
			</subtype>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name/>
					<code/>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype/>
					<inclusion_exclusion>exclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>all</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>any</numRequired>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>atorvastatin 80 mg tablet </name>
								<codeValues>158585</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>ge</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>all</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
			</triedTherapyExclusion>
			<dosing>
				<text>20 mg orally once daily</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>451300</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>30 tablets for 30 days </initPerIntervalDesc>
					<renewPerDayDesc>1 tablet</renewPerDayDesc>
					<renewPerIntervalDesc>30 tablet for 30 days</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur/>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Crestor [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2014</reference>
				<reference>Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB,  Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PWF. 2013 ACC/AHA  guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S1â€“S45.</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
	</diagnoses>
	<precautions>
		<geriatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</geriatric>
		<pregnancy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pregnancy>
		<pediatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pediatric>
		<lactation>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</lactation>
		<allergy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</allergy>
		<sideEffect>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</sideEffect>
		<drugDisease>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</drugDisease>
	</precautions>
	<lists>
		<listDef>
			<name>HMG-CoA Reductase Inhibitors</name>
			<codeValue>16.09</codeValue>
			<listType>adhoc</listType>
			<listItem>
				<name>atorvastatin 20 mg tablet</name>
				<codeValue>03.163181</codeValue>
			</listItem>
			<listItem>
				<name>fluvastatin 40 mg capsule</name>
				<codeValue>03.217974</codeValue>
			</listItem>
			<listItem>
				<name>Lescol 40 mg capsule</name>
				<codeValue>03.294944</codeValue>
			</listItem>
			<listItem>
				<name>Lescol XL 80 mg tablet,extended release</name>
				<codeValue>03.241540</codeValue>
			</listItem>
			<listItem>
				<name>lovastatin 40 mg tablet</name>
				<codeValue>03.184650</codeValue>
			</listItem>
			<listItem>
				<name>Mevacor 40 mg tablet</name>
				<codeValue>03.158596</codeValue>
			</listItem>
			<listItem>
				<name>Pravachol 20 mg tablet</name>
				<codeValue>03.245894</codeValue>
			</listItem>
			<listItem>
				<name>Pravachol 40 mg tablet</name>
				<codeValue>03.150475</codeValue>
			</listItem>
			<listItem>
				<name>pravastatin 20 mg tablet</name>
				<codeValue>03.268217</codeValue>
			</listItem>
			<listItem>
				<name>pravastatin 40 mg tablet</name>
				<codeValue>03.173289</codeValue>
			</listItem>
			<listItem>
				<name>simvastatin 40 mg tablet</name>
				<codeValue>03.209275</codeValue>
			</listItem>
			<listItem>
				<name>Zocor 40 mg tablet</name>
				<codeValue>03.286606</codeValue>
			</listItem>
		</listDef>
	</lists>
</paload>
